ECSP15026152A - NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS - Google Patents
NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTSInfo
- Publication number
- ECSP15026152A ECSP15026152A ECIEPI201526152A ECSP15026152A ECSP15026152A EC SP15026152 A ECSP15026152 A EC SP15026152A EC IEPI201526152 A ECIEPI201526152 A EC IEPI201526152A EC SP15026152 A ECSP15026152 A EC SP15026152A EC SP15026152 A ECSP15026152 A EC SP15026152A
- Authority
- EC
- Ecuador
- Prior art keywords
- muscarinic
- activity
- quinuclidinyl
- antagonists
- adrenergic agonists
- Prior art date
Links
- 239000000048 adrenergic agonist Substances 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- LSUSEBREYXZDHC-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-2-yl carbamate Chemical class C1CN2C(OC(=O)N)CC1CC2 LSUSEBREYXZDHC-UHFFFAOYSA-N 0.000 title 1
- -1 CYCLOHEXYL Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000003551 muscarinic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003681 muscarinic M3 receptor antagonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a nuevos compuestos que tienen doble actividad agonista Beta2 adrenérgica y antagonista muscarínica M3, a composiciones farmacéuticas que los contienen, al procedimiento para su preparación y a su uso en terapias de la vías respiratorias.The present invention relates to new compounds that have double beta2 adrenergic agonist and muscarinic M3 antagonist activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory tract therapies.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12382513 | 2012-12-18 | ||
| US201361750959P | 2013-01-10 | 2013-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP15026152A true ECSP15026152A (en) | 2016-01-29 |
Family
ID=73013111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201526152A ECSP15026152A (en) | 2012-12-18 | 2015-06-18 | NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP15026152A (en) |
-
2015
- 2015-06-18 EC ECIEPI201526152A patent/ECSP15026152A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140182A (en) | NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC B2 AGONISTS AND AS M3 MUSCARINIC ANTAGONISTS | |
| UY35199A (en) | New cyclohexyl and quinuclidinyl carbamate derivatives that have activity as beta2 adrenergic agonists and as M3 muscarinic antagonists | |
| ECSP14013340A (en) | NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGONISTS? 2 AND AS M3 MUSCARINIC ANTAGONISTS | |
| ECSP12012213A (en) | NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGONISTS? 2 AND AS M3 MUSCARINIC ANTAGONISTS | |
| CR20150322A (en) | NEW CARBAMATE DERIVATIVES OF CYCLHEXYL AND QUINUCLIDINYL THAT HAVE ACTIVITY AS B2 ADRENERGIC AGONISTS AND AS M3 MUSCARINIC ANTAGONISTS | |
| CY1123365T1 (en) | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENORECTOR AGENT ACTIVITY | |
| CL2013001677A1 (en) | Compounds derived from azabicyclo [3.2.1] octane; x fernesoid receptor agonist (fxr); process to prepare the compounds; intermediate compound; pharmaceutical composition and pharmaceutical combination that comprise a compound; and use of the compounds in the preparation of medicaments for the treatment of dyslipidemia. | |
| UY36329A (en) | NEW BICYCLE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGENISTS ß2 AND AS M3 MUSCARINIC ANTAGONISTS | |
| DOP2013000307A (en) | TRPV4 ANTAGONISTS | |
| CR20150114A (en) | COVERED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB | |
| BR112015012746A2 (en) | compounds having muscarinic receptor antagonist and beta2-adrenergic receptor agonist activity | |
| GT201500094A (en) | PIRROLOTRIAZINONA DERIVATIVES AS PI3K INHIBITORS | |
| UY32734A (en) | 1-PHOSPHATE RECEPTOR AGONIST COMPOUNDS | |
| UY35708A (en) | NEW COMPOUNDS AS ANTAGONISTS OF THE LISOPHOSPHYTIDIC ACID RECEPTOR | |
| MX2015005931A (en) | DERIVATIVES OF 1- [1- (BENZOIL) -PIRROLIDIN-2-CARBONIL] -PIRROLIDIN-2-CA RBONITRILO. | |
| BR112013025682A2 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, COMBINATION AND DEVICE | |
| UY34080A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES FEXOFENADINE AND PREPARATION METHODS | |
| MX376160B (en) | COMPOUNDS THAT HAVE MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY. | |
| ECSP15026152A (en) | NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS | |
| DOP2015000049A (en) | COVERED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB | |
| UA112586C2 (en) | BENZIMIDAZOLPROLINE DERIVATIVES |